CSI Market
Sign In | Register

Dermata Therapeutics Inc (DRMA) Annual Balance Sheets

Annual · GAAP · USD millions
Access DRMA quarterly Balance Sheets →
Quarterly balance sheet trends provide context on Dermata Therapeutics Inc's liquidity, leverage, and long-term financial structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent7.52
Cash & Short-term Investments7.00
Prepaid Expense And Other Assets Current0.34
Total Current Assets7.86
Other Assets, Noncurrent0.00
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents-
Total Assets7.86
Liabilities
Accounts Payable, Current AC0.46
Accrued Liabilities And Other Liabilities1.18
Total Current Liabilities1.64
Total Long-term Debt0.00
Other liabilities, Noncurrent1.64
Total Liabilities1.64
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock79.46
Retained Earnings / Accumulated Deficit-73.23
Other Equity0.00
Common Stockholder's Equity6.22
Total Stockholder's Equity6.22
Liabilities & Stockholder's Equity7.86
4 historic quarters locked

Sign in to unlock the full Dermata Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Dermata Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 26, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-012992

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.